From September 26, 2023 to September 30, 2023, the company has repurchased 311,958 shares, representing 0.09% for CNY 35.02 million. With this, the company has completed the repurchase of 311,958 shares, representing 0.09% for CNY 35.02 million under the buyback announced on September 27, 2023.
Shanghai Haohai Biological Technology Co., Ltd.
Equities
6826
CNE100001W69
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
32.35 HKD | +0.94% | -1.52% | +12.38% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+12.38% | 1.71B | |
-4.45% | 179B | |
-2.05% | 100B | |
-6.62% | 46.16B | |
+18.16% | 44.81B | |
+9.80% | 44.38B | |
+13.99% | 29.53B | |
+22.31% | 25.83B | |
-7.16% | 23.97B | |
+3.62% | 22.5B |
- Stock Market
- Equities
- 6826 Stock
- News Shanghai Haohai Biological Technology Co., Ltd.
- Tranche Update on Shanghai Haohai Biological Technology Co., Ltd.'s Equity Buyback Plan announced on September 27, 2023.